<DOC>
	<DOCNO>NCT01024270</DOCNO>
	<brief_summary>The primary outcome measure study preoperative cervical width misoprostol administration . The secondary outcome duration cervical dilatation , Hegar number 10 , complication cervical dilation hysteroscopy , misoprostol associate side effect . The cervical width assess perform cervical dilatation , start number 10 Hegar dilator subsequently insert small Hegar dilatators dilator could pass internal o without resistance . The large one could pass record initial cervical width . The mean cervical diameter , oral vaginal misoprostol 400 μg , report 6.0 ± 1.5 mm 7.3 ± 1.6 mm , respectively 4 . The investigator hypothesize equivalence clinical significance difference initial cervical width le 1 mm among group standard deviation initial cervical width 1.6 mm . The estimated sample size 47 patient group ; would able detect equivalent effect group power 80 % type 1 error ( ) 0.017 . Data express mean ± SD ( standard deviation ) median range number ( % ) case .</brief_summary>
	<brief_title>Cervical Priming With Misoprostol Prior Operative Hysteroscopy</brief_title>
	<detailed_description />
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Symptomatic patient suspect intrauterine pathology submucosal myoma , endometrial polyp endometrial pathological finding base transvaginal ultrasound enrol . woman 20 year age sexual contact history woman whose last menstrual period within last two month . Post menopausal woman evidence contraindication allergy PGs sign genital infection , history cervical surgery , endometrial lesion suspect endo exocervical lesion could affect cervical resistance patient candidate surgery .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>endometrial pathology uterus</keyword>
	<keyword>operative hysteroscopy</keyword>
	<keyword>efficacy misoprostol per different route</keyword>
</DOC>